{"transactions":[{"id":938273,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T21:15:29.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":19231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant."}],"balance_after":256026,"source":{"system":"sec-edgar","filing":"0001493152-26-002424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226002424/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-14"}},{"id":939034,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T01:55:18.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":19231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":256026,"source":{"system":"sec-edgar","filing":"0001493152-26-002303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226002303/ownership.xml","form_type":"4"}},{"id":956969,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-30T21:30:30.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1490996,"derivative":{"exercise_price":1.2,"expiration_date":"2035-12-29","underlying":"Class A Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001493152-25-029617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225029617/ownership.xml","form_type":"4"}},{"id":956968,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-30T21:30:30.000Z","date":"2025-12-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":236795,"source":{"system":"sec-edgar","filing":"0001493152-25-029617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225029617/ownership.xml","form_type":"4"}},{"id":960591,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-22T21:30:23.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025."}],"balance_after":111795,"source":{"system":"sec-edgar","filing":"0001493152-25-028780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225028780/ownership.xml","form_type":"4"}},{"id":990979,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-21T21:15:25.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":44379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant."}],"balance_after":111795,"source":{"system":"sec-edgar","filing":"0001493152-25-024631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225024631/ownership.xml","form_type":"4"}},{"id":1309598,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T02:51:24.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":84746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1334746,"derivative":{"exercise_price":2.225,"expiration_date":"2034-12-19","underlying":"Class A Common Stock","underlying_shares":84746},"source":{"system":"sec-edgar","filing":"0001493152-25-001099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225001099/ownership.xml","form_type":"4"}},{"id":1309597,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-07T02:51:24.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":67416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,416 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":67416,"source":{"system":"sec-edgar","filing":"0001493152-25-001099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225001099/ownership.xml","form_type":"4"}},{"id":1759652,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2023-10-17T00:06:20.000Z","date":"2023-08-31","kind":"grant","planned":false,"acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in three successive equal annual installments measured from the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":1250000,"derivative":{"exercise_price":0.324,"expiration_date":"2033-08-31","underlying":"Class A Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0000950170-23-053619","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023053619/ownership.xml","form_type":"4"}},{"id":2440382,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T22:31:57.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":12855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":31790,"source":{"system":"sec-edgar","filing":"0001209191-22-002485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919122002485/doc4.xml","form_type":"4"}},{"id":2549694,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T20:33:40.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":18935,"source":{"system":"sec-edgar","filing":"0001209191-21-059433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121059433/doc4.xml","form_type":"4"}},{"id":2645478,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T13:54:57.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date."}],"balance_after":14000,"derivative":{"exercise_price":4.55,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-21-044691","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121044691/doc4.xml","form_type":"4"}},{"id":2645477,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T13:54:57.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":2713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":16077,"source":{"system":"sec-edgar","filing":"0001209191-21-044691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121044691/doc4.xml","form_type":"4"}},{"id":2758534,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T17:39:57.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":2331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":13364,"source":{"system":"sec-edgar","filing":"0001209191-21-025035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121025035/doc4.xml","form_type":"4"}},{"id":2916334,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T21:58:38.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":1782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":11033,"source":{"system":"sec-edgar","filing":"0001209191-21-002163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121002163/doc4.xml","form_type":"4"}},{"id":3016735,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T20:22:25.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":2616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":9251,"source":{"system":"sec-edgar","filing":"0001209191-20-053130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120053130/doc4.xml","form_type":"4"}},{"id":3092612,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T20:45:14.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":6635,"source":{"system":"sec-edgar","filing":"0001209191-20-040397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120040397/doc4.xml","form_type":"4"}},{"id":3112136,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T20:47:36.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 11, 2020."}],"balance_after":5000,"derivative":{"exercise_price":7.18,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-036315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120036315/doc4.xml","form_type":"4"}},{"id":3183960,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-03T20:41:46.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":1932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":4932,"source":{"system":"sec-edgar","filing":"0001209191-20-023191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120023191/doc4.xml","form_type":"4"}},{"id":3244247,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-27T21:06:49.000Z","date":"2020-02-25","kind":"purchase","acquired":true,"shares":3000,"price":6.2305,"value":18691.5,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-20-013392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120013392/doc4.xml","form_type":"4"}},{"id":3308859,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":69319,"kind":"person","name":"Ling Geoffrey M.D.","position":1,"cik":"0001800097","reported_name":"Ling Geoffrey M.D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-17T21:06:53.000Z","date":"2020-01-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 36 months commencing January 15, 2020."}],"balance_after":10000,"derivative":{"exercise_price":7.29,"expiration_date":"2030-01-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-003937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120003937/doc4.xml","form_type":"4"}}]}